Semaglutide and tirzepatide both went through FDA-recognized shortages, and during that period, some medical providers met patient demand through compounded versions: the same medication formulated by licensed pharmacists, physicians, and outsourcing facilities rather than manufactured as FDA-approved branded products
Injection site reactions , though less common, should also be documented
A 2022 review of the literature, for example, concluded that a 2.4mg dose prescribed for weight management was safe to take for up to two years
Many side effects are transient, appearing when a dose is new and fading as your body adapts
Molecular Cell , 58(6), 947958